Biopharma bounces back as M&A impetus fuels recovery

Wednesday, June 17, 2026Robert BarrieView original

In a midyear report, PwC said that a surge in deals eclipsing the billion-dollar mark fuelled M&A momentum.

Read the full article on the original site.